Correlation Between Axsome Thera and Brickell Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Axsome Thera and Brickell Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axsome Thera and Brickell Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axsome Thera and Brickell Biotech, you can compare the effects of market volatilities on Axsome Thera and Brickell Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axsome Thera with a short position of Brickell Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axsome Thera and Brickell Biotech.

Diversification Opportunities for Axsome Thera and Brickell Biotech

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Axsome and Brickell is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Axsome Thera and Brickell Biotech Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brickell Biotech and Axsome Thera is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axsome Thera are associated (or correlated) with Brickell Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brickell Biotech has no effect on the direction of Axsome Thera i.e., Axsome Thera and Brickell Biotech go up and down completely randomly.

Pair Corralation between Axsome Thera and Brickell Biotech

Given the investment horizon of 90 days Axsome Thera is expected to generate 0.81 times more return on investment than Brickell Biotech. However, Axsome Thera is 1.23 times less risky than Brickell Biotech. It trades about 0.01 of its potential returns per unit of risk. Brickell Biotech is currently generating about -0.05 per unit of risk. If you would invest  7,374  in Axsome Thera on July 8, 2022 and sell it today you would lose (2,524)  from holding Axsome Thera or give up 34.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy97.79%
ValuesDaily Returns

Axsome Thera  vs.  Brickell Biotech Inc

 Performance (%) 
       Timeline  
Axsome Thera 
Axsome Performance
2 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Axsome Thera are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Axsome Thera revealed solid returns over the last few months and may actually be approaching a breakup point.

Axsome Price Channel

Brickell Biotech 
Brickell Performance
0 of 100
Over the last 90 days Brickell Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in November 2022. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Axsome Thera and Brickell Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Axsome Thera and Brickell Biotech

The main advantage of trading using opposite Axsome Thera and Brickell Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axsome Thera position performs unexpectedly, Brickell Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brickell Biotech will offset losses from the drop in Brickell Biotech's long position.
Axsome Thera vs. Turquoise Hill Resources
Axsome Thera vs. Element 29 Resources
Axsome Thera vs. Lundin Mng Corp
Axsome Thera vs. Freeport-Mcmoran
The idea behind Axsome Thera and Brickell Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Brickell Biotech vs. Microsoft Corp
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go